Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adenocarcinoma Of Esophagus × Irinotecan × Clear all

Phase

Phase 2 18 Phase 1 4 Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5 Stomach Neoplasms 3 Upper Gastrointestinal Tumours 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Neutropenia 1 Adenocarcinoma Of Esophagus 1

Interventions

Surgical Procedures, Operative 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Cryotherapy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02366819 2025-06-13

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡